A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Clinical trial NCT06582264 · COMPLETED

Trial details

NCT number: NCT06582264
Sponsor: Microbiotica Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2024-09-27
Primary completion: 2026-01-08
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.